Forum for Regenerative Medicine Companies Seeking Capital to Be Held April 2010
The April 2010 Translational Forum is the only regenerative medicine conference globally that features investor funding and business model panels followed by a venture forum designed specifically for industry.
Additionally, the Translational Forum will include participation from executives from more than 30 companies that have successfully raised money for regenerative medicine commercialization. Companies are invited to submit executive summaries and supporting slides.
To learn more, click here. To register, click here.
Open to any company globally, the April 8, 2010 venture forum is designed for both emerging and mid-stage companies, with opportunities for 15 companies commercializing technology in the areas of:
- Cell Therapies
- Tissue and Organ Therapies
- Biomaterials
- Tools and Enabling Technologies
Venture Funds and Investors Confirmed (as of January 6, 2010)
- Safeguard Scientifics
- Scheer and Associates
- DeNovo Ventures
- Excel Venture Management
- InterSouth Partners
- Livingston Securities
- Proteus Ventures
- Quaker BioVentures
Submissions
Submit your executive summary and slides to executivesummaries@rmconferences.org. In the body of the email accompanying your material, please provide the names, affiliations and contact details, including email addresses, for all participants, and designate the presenter. Deadline for submissions is January 31, 2010.
Selected Companies
Companies that are selected will be able to register one company member free of charge and receive tabletop space in the forum exhibition area. Notification to presenting companies will be by February 8, 2010.
Call for Scientific Abstracts Still Open
The forum is still taking abstracts relating to novel translational methods, clinical trials, tools, techniques, etc. The deadline for submission is January 29, 2010. Submit your abstracts to abstracts@rmconferences.org.
About the Translational Regenerative Medicine Forum
The Translational Regenerative Medicine Forum is designed to be the premier international event for leaders in regenerative medicine, representing academic and clinical research, biotechnology industry, health care policy, regulatory, reimbursement and venture investment interests. Held annually in Winston-Salem, N.C., the forum seeks to advance the field of regenerative medicine and health care innovation through the sharing of scientific discoveries, best practices and business models. Reflecting the global scope of regenerative medicine, the meeting will feature keynote speakers and panelists from both a U.S. and international perspective, including critical areas such as clinical trial design and funding.
To foster interaction between investors and entrepreneurs, the forum will showcase regenerative medicine companies presenting in front of an audience of venture capitalists and corporate venture executives. A full-day media academy precedes the forum, in order to educate reporters and editors on the basics of regenerative medicine (stem cells sources, technologies, biomaterials) and pathways to deliver new therapies to patients.
Tags: 